Understanding a specific genetic cause of retinal degeneration
Characterization of DHDDS RP59 Knockin Models of Retinitis Pigmentosa
This study is looking at a specific type of retinitis pigmentosa called RP59, which is caused by changes in a gene, and researchers are using specially designed mice to learn more about how these changes affect vision, hoping to find new ways to help people with this condition.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11042720 on NIH RePORTER |
What this research studies
This research focuses on retinitis pigmentosa-59 (RP59), a genetic condition leading to retinal degeneration caused by mutations in the DHDDS gene. Researchers have created mouse models using advanced gene editing techniques to study how these mutations affect retinal health. By examining these models, the team aims to uncover the underlying mechanisms of RP59 and how it leads to vision loss, which could inform future treatments for patients with this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with retinitis pigmentosa, particularly those with mutations in the DHDDS gene.
Not a fit: Patients with retinitis pigmentosa caused by mutations in genes other than DHDDS may not benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could lead to new insights and potential therapies for patients suffering from retinitis pigmentosa and related retinal diseases.
How similar studies have performed: Previous research using similar genetic modeling approaches has shown promise in understanding and potentially treating inherited retinal diseases.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Nguyen, Mai N — University of Alabama at Birmingham
- Study coordinator: Nguyen, Mai N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.